Ravi Kumar Vyas Devambatla

Design, Synthesis, and Preclinical Evaluation of 4-Substituted-5-methyl-furo[2,3-<i>d</i>]pyrimidines as Microtubule Targeting Agents That Are Effective against Multidrug Resistant Cancer Cells

Ravi Kumar Vyas Devambatla, Ojas A. Namjoshi, Shruti Choudhary et al. · Journal of Medicinal Chemistry · 2016 · 33 citations · Full text

A Small Molecule with Anticancer and Antimetastatic Activities Induces Rapid Mitochondrial-Associated Necrosis in Breast Cancer

Anja Bastian, Jessica E. Thorpe, Bryan C. Disch et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 28 citations · Full text

Discovery of Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> Thymidylate Synthase for Opportunistic Infections

Nilesh Zaware, Hitesh Kumar Sharma, Jie Yang et al. · ACS Medicinal Chemistry Letters · 2013 · 25 citations · Full text

SNi′ displacements with main group organometallics

Ravi Kumar Vyas Devambatla, Ranganadh Velagaleti, Nageswari Yarravarapu et al. · Tetrahedron · 2012 · 19 citations

Inorganic Chemistry, Sni′ Displacements, Main Group Chemistry +1

Synthesis of N4-(substituted phenyl)-N4-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cells

Aleem Gangjee, Nilesh Zaware, Ravi Kumar Vyas Devambatla et al. · Bioorganic & Medicinal Chemistry · 2012 · 17 citations · Full text

New Microtubule, Medicinal Chemistry, Multidrug Resistant Cells +7